Motor neuron diseases: Comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain

Radiology

Volumn 212, Issue 3, 1999, Pages 763-769

  Chan, Stephen ^a   Shungu, Dikoma C ^a   Douglas Akinwande, Annette ^a   Lange, Dale J ^a   Rowland, Lewis P ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Brain, cortex; Brain, diseases; Brain, MR; Magnetic resonance (MR), comparative studies; Magnetic resonance (MR), spectroscopy

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MOTOR CORTEX; MOTOR NEURON DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PYRAMIDAL TRACT;

EID: 0032843024     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.212.3.r99au35763     Document Type: Article

References (27)

1. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different cell types. J Neurosci 1993; 13: 981-989.
2. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991; 45:37-45.
3. Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994; 44:1933-1938.
4. Jones AP, Gunawardena WJ, Coutinho CM, Gatt JA, Shaw IC, Mitchell JD. Preliminary results of proton magnetic resonance spectroscopy in motor neuron disease (amyotrophic lateral sclerosis). J Neurol Sci 1995; 129(suppl):85-89.
5. Giroud M, Walker P, Bernard D, et al. Reduced brain N-acetylaspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis. Neurol Res 1996; 18:241-243.
6. Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997; 48:878-881.
7. Block W, Karitsky J, Traber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease. Arch Neurol 1998; 55:931-936.
8. Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998; 50:1800-1805.
9. Berger MS, Cohen WA, Ojemann GA. Correlation of motor cortex brain mapping data with magnetic resonance imaging. J Neurosurg 1990; 72:383-387.
10. 2H NMR spectroscopy using water as an internal intensity reference. Magn Reson Med 1992; 28:105-121.
11. Press WH, Flannery BP, Teukolsy SA, Vetterling WT. Integration of functions. In: Numerical recipes in C: the art of scientific computing. New York, NY: Cambridge University Press, 1988; 111-141.
12. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8:283-298.
13. Desmond DW, Tatemichi TK, Hanzawa L. The telephone interview for cognitive status (TICS): reliability and validity in a stroke sample. Int J Geriatr Psychiatry 1994; 9:803-807.
14. Cheung G, Gawal MJ, Cooper PW, Farb RI, Ang LC. Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995; 194:263-270.
15. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Brain 1992; 115:495-520.
16. Friedman DP, Tartaglino LM. Amyotrophic lateral sclerosis: hyperintensity of the corticospinal tracts on MR images of the spinal cord. AJR 1993; 160:604-606.
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 30:159-174.
18. Hofmann E, Ochs G, Petzl A, Warmuth-Metz M. The corticospinal tract in amyotrophic lateral sclerosis: an MRI study. Neuroradiology 1998; 40:71-75.
19. Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L. Central nervous system trans-synaptic effects of acute axonal injury: a H-1 magnetic resonance spectroscopy study. Magn Reson Med 1995; 33:595-600.
20. Brownell B, Oppenheimer DR, Hughes JT. Central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970; 33:338-357.
21. Lawyer T, Netsky MG. Amyotrophic lateral sclerosis: clinicoanatomic study of 53 cases. Arch Neurol Psychiatry 1953; 69: 171-192.
22. Yagashita A, Nakano I, Oda M, et al. Location of the corticospinal tract in the internal capsule at MR imaging. Radiology 1994; 191:455-460.
23. Marti-Fabregas J, Pujol J. Selective involvement of the pyramidal tract on magnetic resonance imaging in primary lateral sclerosis. Neurology 1990; 40:1799-1800.
24. Ishikawa K, Nagura H, Yokota T, Yamanouchi H. Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis. Ann Neurol 1993; 33:218-222.
25. Oba H, Araki T, Ohtomo K, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993; 189:843-846.
26. Norbash AM, Glover GH, Enzmann DR. Intracerebral lesion contrast with spin-echo and fast spin-echo pulse sequences. Radiology 1992; 185:661-665.
27. Imon Y, Yamaguchi S, Katayama S, et al. A decrease in cerebral cortex intensity on T2-weighted images with aging of normal subjects. Neuroradiology 1998; 40:76-80.